ResultsIQ

ResultsIQ › Latest results › Aptus Pharma Ltd

Aptus Pharma Ltd Q2 FY27 results deck summary

NSE: APPL · BSE: 544529

Results deck of 23 Oct 2026, summarised by AI from the filing.

Aptus Pharma reports H1 FY27 revenue of ₹48.92 cr with nearly twofold YoY growth and targets 46% India coverage by March 2027.

Key takeaways

  1. H1 revenue H1 revenue was ₹48.92 cr with nearly twofold year-on-year revenue growth for the same period.
  2. Coverage target Management targets 46% geographic coverage across India by March 2027.

Original filing on BSE

Aptus Pharma Ltd earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.